Advertisement

Document › Details
Twist Bioscience Corporation. (7/25/19). "Press Release: Twist Bioscience Enhances DNA Storage Capabilities Through Agreement With Imagene SA". San Francisco, CA.
-- Agreement Enables Twist to Securely Store DNA With Digital Data Encoded --
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has entered into an agreement with Imagene SA, where Imagene will provide Twist with an encapsulation service to store DNA through its DNAshell® technology to store digital data encoded in DNA for thousands of years.
“This agreement with Imagene provides the next step in the continuum on DNA digital data storage and fits within our strategy to cover all aspects of the process efficiently to enable the development of DNA as a digital storage medium,” commented Emily Leproust, Ph.D., CEO of Twist Bioscience. “We believe the DNAshell® technology allows us to encapsulate the DNA-stored digital data securely, protecting it for eternity from any elements including radiation, and eliminating the need for continued copying of digital data due to degradation experienced in other forms of storage today.”
“Twist Bioscience, through its silicon platform, has demonstrated the ability to store large amounts of data on DNA, providing a high density, long-term solution to digital data storage, and we are excited to see them grow this product offering,” said Sophie Tuffet, CEO and Chairman of the Executive Board of Imagene. “We are happy to be partnering with Twist and providing them with our disruptive DNAshell® technology to safely store DNA with digital data encoded.”
About Imagene’s DNAshell® technology
DNAshell® technology enables the confinement of desiccated DNA molecules under an anoxic and anhydrous inert atmosphere inside airtight, laser-engraved, stainless steel minicapsules. In the absence of the alteration factors water, oxygen, and light, natural or synthetic DNA can be stored at room temperature for a nearly limitless period of time. DNAshell® is a robust, standalone storage platform enabling the safe and stable storage and distribution of material with zero ongoing energy costs. The high DNA storage capacity of these capsules allows the storage of enormous amounts of data in a small volume. Imagene’s DNAshell® technology has been successfully extended to the preservation of RNA, blood, and microorganisms for applications in biobanking and molecular diagnostics. Imagene is both a service provider and instrumentation supplier.
For more information, please email [email protected] or visit www.imagene.eu.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Investor Contact:
Argot Partners
Maeve Conneighton
212-600-1902
[email protected]
Media Contact:
Angela Bitting
925-202-6211
[email protected]
Record changed: 2023-06-05 |
Advertisement

More documents for Twist Bioscience (Group)
- [1] Twist Bioscience Corporation. (12/18/23). "Press Release: Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference". South San Francisco, CA....
- [2] Twist Bioscience Corporation. (10/5/23). "Press Release: Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million". Hamburg & Singapore....
- [3] Twist Bioscience Corporation. (9/27/23). "Press Release: Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases". South San Francisco, CA & Rafael, CA & Barcelona....
- [4] Twist Bioscience Corporation. (2/8/22). "Press Release: C2i Genomics Partners with Twist Bioscience to Launch Reference Materials for Whole-Genome Cancer Detection". New York, NY & South San Francisco, CA....
- [5] Twist Bioscience Corporation. (9/9/21). "Press Release: Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration". South San Francisco, CA & Ingelheim....
- [6] Twist Bioscience Corporation. (4/28/21). "Press Release: Twist Bioscience and Vivlion Partner to Generate gRNA Libraries for CRISPR Applications". South San Francisco, CA & Frankfurt am Main....
- [7] Twist Bioscience Corporation. (4/14/21). "Press Release: Pure Biologics Selects Twist Bioscience to Expand Phage Display Technology Capabilities". South San Francisco, CA....
- [8] Twist Bioscience Corporation. (10/13/20). "Press Release: Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies". South San Francisco, CA, Amsterdam & New York, NY....
- [9] Twist Bioscience Corporation. (2/26/20). "Press Release: Twist Bioscience and Sophia Genetics Collaborate to Offer Optimized Genomic Solutions". South San Francisco, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top